Mereo BioPharma Group plc (MREO)
USD 3.31
(-2.65%)
USD 3.31
(-2.65%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -21.13 Million | -38.82 Million | -5.23 Million | -28.34 Million | -45.93 Million | -23.13 Million |
| Net Income | -29.46 Million | -36.09 Million | 14.24 Million | -166.45 Million | -41.11 Million | -37.3 Million |
| Depreciation & Amortization | 1.06 Million | 727 Thousand | 642 Thousand | 1.59 Million | 1.57 Million | 37.79 Thousand |
| Deferred income taxes | 1.26 Million | - | -34.98 Million | 133.13 Million | 69 Thousand | 7.61 Million |
| Stock-based compensation | 4.92 Million | 4.76 Million | 4.45 Million | 2.12 Million | 1.63 Million | 2.18 Million |
| Change in working capital | -1.59 Million | 1.82 Million | -1.84 Million | -3.41 Million | -7.66 Million | 2.4 Million |
| Other non-cash items | 2.67 Million | -9.13 Million | 13.4 Million | 5.22 Million | -429 Thousand | 1.91 Million |
| Investing Cash Flow | -419 Thousand | 1.49 Million | -421 Thousand | 1.49 Million | 43.29 Million | 251.55 Thousand |
| Investments in PPE | -419 Thousand | -10 Thousand | -535 Thousand | -16 Thousand | -21 Thousand | -35.53 Thousand |
| Acquisitions | - | - | - | -354 Thousand | 10.07 Million | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | 32.86 Million | - |
| Other Investing Activities | -419 Thousand | 1.5 Million | 114 Thousand | 1.86 Million | 377 Thousand | 287.09 Thousand |
| Financing Cash Flow | 7.97 Million | -784 Thousand | 77.65 Million | 34.73 Million | -5.71 Million | -2.07 Million |
| Debt repayment | -3.18 Million | -937 Thousand | -692 Thousand | -21.88 Million | -2.21 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | -998 Thousand | -306.83 Thousand |
| Common Stock Issuance | 11.6 Million | - | 78.53 Million | 20.13 Million | - | 273.06 Thousand |
| Other Financing Activities | -444 Thousand | 153 Thousand | -188 Thousand | 36.48 Million | -2.5 Million | -2.03 Million |
| Accounts receivables | 456 Thousand | 695 Thousand | -589 Thousand | 141 Thousand | -936 Thousand | - |
| Accounts payables | -1.26 Million | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.26 Million | 1.12 Million | -1.25 Million | -3.55 Million | -6.73 Million | - |
| Cash at beginning of period | 68.18 Million | 94.29 Million | 23.46 Million | 16.34 Million | 25.04 Million | 50.04 Million |
| Cash at end of period | 57.42 Million | 56.33 Million | 94.29 Million | 23.46 Million | 16.34 Million | 25.04 Million |
| Capital Expenditure | -419 Thousand | -10 Thousand | -535 Thousand | -16 Thousand | -21 Thousand | -35.53 Thousand |
| Effect of forex changes on cash | 2.81 Million | 145 Thousand | -1.16 Million | -769 Thousand | -349 Thousand | -43.86 Thousand |
| Net cash flow / Change in cash | -10.76 Million | -37.96 Million | 70.82 Million | 7.12 Million | -8.69 Million | -25 Million |
| Free Cash Flow | -21.55 Million | -38.83 Million | -5.77 Million | -28.35 Million | -45.95 Million | -23.17 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -12.26 Million | -8.94 Million | -29.46 Million | -7.7 Million | -8 Million | -13.6 Million |
| Depreciation & Amortization | 257.28 Thousand | 274.84 Thousand | 1.06 Million | 361.09 Thousand | 368.19 Thousand | 498.2 Thousand |
| Deferred income taxes | - | - | 1.26 Million | 8.77 Million | - | -8.77 Million |
| Stock-based compensation | 2.08 Million | 2.05 Million | 4.92 Million | 1.23 Million | 1.28 Million | 800.57 Thousand |
| Change in working capital | 1.66 Million | -1.5 Million | -1.59 Million | 3.35 Million | 3.2 Million | -7.85 Million |
| Other non-cash items | 3.08 Million | 3.08 Million | 2.67 Million | 644.02 Thousand | 673.2 Thousand | 12.03 Million |
| Investing Cash Flow | 381.25 | -699.6 Thousand | -419 Thousand | -292.93 Thousand | -289.43 Thousand | -415.58 Thousand |
| Investments in PPE | 381.25 | -699.6 Thousand | -419 Thousand | 415.58 Thousand | - | -415.58 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 1000.00 | -700 Thousand | -419 Thousand | -292.93 Thousand | -289.43 Thousand | 83.18 Thousand |
| Financing Cash Flow | 46.79 Million | - | 7.97 Million | 4.56 Million | 4.54 Million | -178.81 Thousand |
| Debt repayment | -219.06 Thousand | - | -3.18 Million | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 47.01 Million | - | 11.6 Million | -2466.35 | - | 2466.35 |
| Other Financing Activities | 46.78 Million | - | -444 Thousand | 4.56 Million | 4.54 Million | 97.42 Thousand |
| Accounts receivables | -370.53 Thousand | -476.72 Thousand | - | 3.51 Million | 3.36 Million | -6.8 Million |
| Accounts payables | 241.18 Thousand | 126.92 Thousand | -1.26 Million | -1.26 Million | - | -2.3 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.78 Million | -1.15 Million | 1.26 Million | -165 Thousand | -165 Thousand | -1.04 Million |
| Cash at beginning of period | 48.66 Million | 57.42 Million | 68.18 Million | -792.65 Thousand | -594.59 Thousand | 67.76 Million |
| Cash at end of period | 87.43 Million | 48.66 Million | 57.42 Million | 2.88 Million | 2.7 Million | 53.54 Million |
| Capital Expenditure | 381.25 | -699.6 Thousand | -419 Thousand | 415.58 Thousand | - | -415.58 Thousand |
| Effect of forex changes on cash | -107 Thousand | -70 Thousand | 2.81 Million | 1.51 Million | 1.51 Million | -1.51 Million |
| Net cash flow / Change in cash | 38.77 Million | -8.76 Million | -10.76 Million | 3.67 Million | 3.29 Million | -14.22 Million |
| Free Cash Flow | -7.91 Million | -8.68 Million | -21.55 Million | -1.7 Million | -2.47 Million | -17.14 Million |
SCHW
JCHAC
SAREGAMA
603867
2185
DKS